호르몬 피임약 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 투여 경로별, 호르몬 유형별, 연령층별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Hormonal Contraceptives Market size was valued at USD 17.84 Billion in 2024 and is poised to grow from USD 18.61 Billion in 2025 to USD 26.06 Billion by 2033, growing at a CAGR of 4.3% during the forecast period (2026-2033).

The global market for hormonal contraceptives is experiencing significant growth driven by rising demand for effective birth control methods, high usage rates among women, and increased awareness of reproductive health. Approximately 82% of women of reproductive age utilize some form of contraception, with many employing multiple methods. A large majority, around 85%, seek to prevent pregnancy, while others utilize contraceptives for medical conditions or to prevent sexually transmitted infections. Initiatives like the Contraceptive Access Initiative and the National Family Planning Program in India enhance accessibility to hormonal contraceptives, further propelling market growth. Additionally, ongoing funding efforts for new contraceptive options, such as desogestrel, continue to expand the landscape of available choices, contributing to the market's upward trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormonal Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hormonal Contraceptives Market Segments Analysis

Global Hormonal Contraceptives Market is segmented by Product Type, Route of Administration, Hormone Type, Age Group, End User and region. Based on Product Type, the market is segmented into Oral Contraceptives, Contraceptive Patch, Implantable Rod, Vaginal Ring, Intrauterine Device (IUD), Injectable Birth Control and Emergency Contraceptive Pills. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravaginal and Subdermal. Based on Hormone Type, the market is segmented into Combined Hormone and Progestin Only. Based on Age Group, the market is segmented into 18-25 Years, 26-35 Years and 36+ Years. Based on End User, the market is segmented into Household, Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hormonal Contraceptives Market

The global market for hormonal contraceptives is significantly driven by heightened awareness of family planning and the increasing levels of education among women. This trend has been essential in promoting access to modern contraceptive methods, particularly in middle- and low-income countries, where initiatives focused on improving reproductive health are gaining momentum. As more women become informed about their options, the usage of hormonal contraceptive methods, including injectables and oral pills, continues to rise. This growing recognition of the importance of family planning contributes to the expanding demand and acceptance of hormonal contraceptives worldwide, reflecting a broader shift towards empowering women in their reproductive choices.

Restraints in the Global Hormonal Contraceptives Market

The global market for hormonal contraceptives faces significant challenges due to deeply entrenched cultural norms, religious conservatism, and patriarchal structures prevalent in regions like the Middle East, South Asia, and parts of Sub-Saharan Africa. In these areas, unmarried women and adolescents often grapple with societal stigma and community judgment, which severely restrict their ability to access reproductive healthcare. This resistance limits not only individual choice but also the overall demand for hormonal contraceptives, thereby impeding the market's potential for growth and expansion. Overcoming these barriers requires social change and enhanced education around reproductive rights and health.

Market Trends of the Global Hormonal Contraceptives Market

The Global Hormonal Contraceptives market is witnessing a significant trend driven by the rapid digital transformation within the contraceptive industry. The emergence of app-based prescription services and telemedicine is enhancing accessibility and convenience, particularly for millennial and Gen Z consumers who prioritize privacy and user-friendliness. Healthcare providers are increasingly adopting these digital platforms to streamline prescription management, track compliance, and improve consultations. This innovation not only boosts adherence rates but also elevates user satisfaction, reflecting a shift towards integrated healthcare solutions that cater to the evolving preferences of a tech-savvy population. Consequently, this trend is shaping the future of hormonal contraceptives.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Hormonal Contraceptives Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Oral Contraceptives
• Contraceptive Patch
• Implantable Rod
• Vaginal Ring
• Intrauterine Device (IUD)
• Injectable Birth Control
• Emergency Contraceptive Pills

Global Hormonal Contraceptives Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Transdermal
• Intravaginal
• Subdermal

Global Hormonal Contraceptives Market Size by Hormone Type & CAGR (2026-2033)

• Market Overview
• Combined Hormone
• Progestin Only

Global Hormonal Contraceptives Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• 18-25 Years
• 26-35 Years
• 36+ Years

Global Hormonal Contraceptives Market Size by End User & CAGR (2026-2033)

• Market Overview
• Household
• Hospitals
• Clinics

Global Hormonal Contraceptives Market Size & CAGR (2026-2033)

• North America (Product Type, Route of Administration, Hormone Type, Age Group, End User)
  • US
  • Canada
• Europe (Product Type, Route of Administration, Hormone Type, Age Group, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Route of Administration, Hormone Type, Age Group, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Route of Administration, Hormone Type, Age Group, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Route of Administration, Hormone Type, Age Group, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HRA Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theramex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Enterprises Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aimmune Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations